2,723 hedge funds and large institutions have $145B invested in Pfizer in 2021 Q2 according to their latest regulatory filings, with 187 funds opening new positions, 1,279 increasing their positions, 997 reducing their positions, and 97 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

2% more funds holding

Funds holding: 2,6662,723 (+57)

0.55% more ownership

Funds ownership: 65.76%66.31% (+0.55%)

10% less call options, than puts

Call options by funds: $2.23B | Put options by funds: $2.47B

Holders
2,723
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
70
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.23B
Puts
$2.47B
Net Calls
Net Calls Change

Top Buyers

1 +$396M
2 +$359M
3 +$207M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$179M
5
N
Natixis
France
+$173M

Top Sellers

1 -$316M
2 -$292M
3 -$182M
4
Bank of America
Bank of America
North Carolina
-$154M
5
JP Morgan Chase
JP Morgan Chase
New York
-$144M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$911M
27
$891M
28
$855M
29
$821M
30
$788M
31
$737M
32
$708M
33
$687M
34
$672M
35
$667M
36
$603M
37
$524M
38
$522M
39
$498M
40
$483M
41
$482M
42
$480M
43
$474M
44
$461M
45
$457M
46
$450M
47
$446M
48
$445M
49
$443M
50
$422M